Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 9Unknown 6Recruiting 5Withdrawn 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Gastrointestinal 52Thoracic 33Breast 33Genitourinary 25Gynecologic 23Head & Neck 19CNS 19Tumor-Agnostic 17Lymphoid 16Sarcoma 13Other hematologic neoplasm 11Dermatologic 11Plasma cell 5Myeloid 5Other solid neoplasm 3Endocrine 2NET 1Classical hematology 1

Conditions

Thrombosis 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

venetoclax 33fludarabine 32Cyclophosphamide 31Azacitidine 29Specimen Handling 27Biopsy 20Cytarabine 19fludarabine phosphate 15Whole-Body Irradiation 15Stem Cell Transplantation 15Decitabine 15ruxolitinib 14Tacrolimus 14Melphalan 14Busulfan 14Mycophenolic Acid 13Injections 11asciminib 10decitabine and cedazuridine drug combination 9Thiotepa 8Methotrexate 8Hematopoietic Stem Cell Transplantation 8X-Rays 7Granulocyte Colony-Stimulating Factor 7Magnetic Resonance Spectroscopy 6Idarubicin 6Filgrastim 6Cyclosporine 611-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 6tagraxofusp 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Blood Specimen Collection × Myeloid × Clear all
NCT06480591 2026-05-22

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Wake Forest University Health Sciences

Recruiting
35 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

NCT06510868 2026-03-05

MDS & PRRT

University Health Network, Toronto

Recruiting
45 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05983991 2025-12-26

GATA-2

Institut Claudius Regaud

Phase NA Recruiting
150 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05839717 2024-12-17

CLOJAK

University Hospital, Bordeaux

Recruiting
120 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

NCT06130787 2024-09-27

BIO-TIMER

University Hospital, Clermont-Ferrand

Phase NA Recruiting
321 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡